00:00:00:00
LIVE WEBINAR
Presented by attorneys Jeffrey S. Baird and Cara C. Bachenheimer, from Brown & Fortunato
After being on pause for years, competitive bidding is back — reinstated under the CY 2026 Home Health Prospective Payment System Final Rule. This rule introduces significant structural changes to the Competitive Bidding Program (CBP), a program with already pre-existing barriers. Along with the competitive bidding updates, the Centers for Medicare & Medicaid (CMS) is also imposing additional accreditation requirements and stricter provider enrollment requirements and is revising change in majority ownership (CIMO) requirements. CMS has also issued a six-month moratorium against the issuance of new Provider Transaction Access Numbers (PTANs).
In this webinar, you’ll get straightforward guidance on what DME suppliers need to know about all these updates — what’s changing, what’s most challenging, and what steps you can take now to navigate the new landscape with less risk and more confidence.
Attorney, Brown & Fortunato
Jeff Baird has been representing clients for more than 45 years. On a proactive basis, he advises healthcare providers on issues governed by the federal anti-kickback statute, federal physician self-referral statute (“Stark”), federal beneficiary inducement statute, federal telephone solicitation statute, federal False Claims Act, HIPAA, and their multiple state counterparts. Baird advises clients on working collaboratively with CMS, CMS contractors (e.g., DME MACs, UPICs, and Provider Enrollment), Food and Drug Administration, Office of Inspector General, Federal Trade Commission, Drug Enforcement Agency, state Boards of Pharmacy, state Attorneys General, state Medicaid programs, PBMs, Medicare Advantage Plans, and Medicaid Managed Care Plans. He advises clients on healthcare regulatory issues arising out of acquisitions, sales, mergers and joint ventures. Baird defends healthcare providers that are targets of civil and criminal investigations brought by the Department of Justice, Office of Inspector General, Food and Drug Administration, Drug Enforcement Agency, and state Attorneys General.
Attorney, Brown & Fortunato
Cara Bachenheimer is a trusted advisor in legislative, regulatory and policy matters related to Medicare, Medicaid, and other third-party payment programs. Based in Washington D.C., Bachenheimer represents healthcare manufacturers, HME suppliers, pharmacies, infusion companies, home health agencies, hospitals, and other healthcare providers throughout the United States. For 40 years, she has been working on behalf of companies and the industry with the Centers for Medicare and Medicaid Services (CMS), the Food and Drug Administration (FDA), and other federal agencies. Bachenheimer has held multiple leadership positions in industry associations such as the American Association for Homecare (AAH), the National Coalition for Assistive & Rehab Technology (NCART), and the Health Industry Distributors Association (HIDA), as well as with national consumer organizations such as United Spinal Association and Paralyzed Veterans of America. Her award highlights include “Home Care Champion” by the American Association for Homecare, the “Home Care Caring” award by Home Care Magazine and HME News’ “Top 10 Most Influential People in the Industry.” Bachenheimer is a frequent speaker at national, regional, and state meetings and conferences, and often writes articles for industry publications such as HME News and Home Care Magazine. Bachenheimer and her husband have two children and enjoy traveling and spending time with their family.
The most important competitive bidding requirements and what they mean for your organization
What’s changing with accreditation, provider enrollment, and CIMO and why it matters
What steps to take to meet competitive bidding requirements and how to avoid common compliance pitfalls
How to comply with new accreditation, provider enrollment, and CIMO requirements — and how to navigate risks tied to the moratorium on new PTANs
What the more challenging aspects of competitive bidding and related initiatives look like in practice and what may come next from CMS
WellSky® is one of America’s largest and most innovative healthcare technology companies, leading the movement for intelligent, coordinated care.
In today’s value-based care environment, WellSky connects providers, payers, health systems, life sciences companies, and community organizations through AI-powered software, analytics, and services.
Our solutions help organizations scale smarter, collaborate more effectively, and unlock data-driven insights.
The result is better alignment across all dimensions of clinical and social care — supporting better outcomes and lower costs.
WellSky serves more than 20,000 client sites — including the largest hospital systems, blood banks, cell therapy labs, home health and hospice franchises, post-acute providers, government agencies, and human services organizations.
With more than 40 years of industry expertise further amplified by AI, WellSky anticipates clients’ needs and innovates relentlessly to shape the future of coordinated care.
For more information, visit wellsky.com.
